Who to call at MeiraGTx Holdings plc, and when
Fundz watches for the moments MeiraGTx Holdings plc starts buying, and tells you who to reach.
- An alert the day MeiraGTx Holdings plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MeiraGTx Holdings plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MeiraGTx Holdings plc. With Fundz connected, it knows.
Contract Type
collaboration_agreement
Description
On November 7, 2025, MeiraGTx Holdings plc entered into a strategic collaboration and license agreement with Eli Lilly and Company. This agreement focuses on the research, development, and commercialization of genetic medicines in the ophthalmology sector. Under the terms of the agreement, MeiraGTx grants Lilly exclusive, worldwide rights for these endeavors. This collaboration seeks to advance innovative treatments for ocular diseases.
Quick answer
MeiraGTx Enters Strategic Collaboration Agreement with Eli Lilly (November 10, 2025). MeiraGTx Holdings plc is based in New York, New York, United States.
- What agreement did MeiraGTx Holdings plc announce on November 10, 2025?
- On November 7, 2025, MeiraGTx Holdings plc entered into a strategic collaboration and license agreement with Eli Lilly and Company. This agreement focuses on the research, development, and commercialization of genetic medicines in the ophthalmology sector.
- What does MeiraGTx Holdings plc do?
- MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs.
- Where is MeiraGTx Holdings plc based?
- MeiraGTx Holdings plc is based in New York, New York, United States.
Source: Fundz verified event record.
Related People
MeiraGTx Holdings plc signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.